Skip to main content
Daily Report

Daily Sepsis Research Analysis

05/23/2025
3 papers selected
3 analyzed

Three studies advance sepsis science across pathogen genomics and host-targeted mechanisms. A human E. coli bacteremia genomics study links an ETT2 type III secretion system with higher mortality and demonstrates complement evasion and cytotoxicity mechanisms. Two translational works show extracellular vesicle-driven pathways: adipose stem cell EVs protect kidneys via ADAM17/MerTK-mediated efferocytosis, while neutrophil-derived exosomal MMP9 drives NET formation and multi-organ injury.

Summary

Three studies advance sepsis science across pathogen genomics and host-targeted mechanisms. A human E. coli bacteremia genomics study links an ETT2 type III secretion system with higher mortality and demonstrates complement evasion and cytotoxicity mechanisms. Two translational works show extracellular vesicle-driven pathways: adipose stem cell EVs protect kidneys via ADAM17/MerTK-mediated efferocytosis, while neutrophil-derived exosomal MMP9 drives NET formation and multi-organ injury.

Research Themes

  • Pathogen genomics and virulence determinants in sepsis
  • Extracellular vesicles modulating innate immunity and organ injury
  • Translational targets for sepsis-associated organ dysfunction

Selected Articles

1. Escherichia coli Type III Secretion System 2 Is Associated With Patient Mortality in Bloodstream Infections.

81.5Level IIICohort
The Journal of infectious diseases · 2025PMID: 40404560

In 193 E. coli bacteremia genomes, co-presence of ETT2 and an accessory region (ETT2-AR) was independently associated with higher in-hospital attributable mortality. Mechanistic assays showed that ETT2/ETT2-AR conferred resistance to classical complement activation, enhanced bacterial adhesion, and increased mammalian cell death.

Impact: This study links specific bacterial virulence loci to patient mortality and experimentally demonstrates mechanisms of complement evasion and cytotoxicity. It provides actionable biomarkers for risk stratification and potential targets for anti-virulence therapies.

Clinical Implications: Genomic screening for ETT2/ETT2-AR in E. coli bacteremia could identify high-risk patients and inform early aggressive management. The T3SS-like apparatus suggests potential for targeted anti-virulence interventions or complement-based adjunctive strategies.

Key Findings

  • Co-presence of ETT2 and ETT2-AR in 21% (41/193) of E. coli bacteremia genomes was associated with increased in-hospital attributable mortality (adjusted OR 3.0, 95% CI 1.1–7.9, p=0.03).
  • ETT2/ETT2-AR inhibited classical complement pathway activation, increasing resistance to complement-mediated growth restriction.
  • These islands enhanced adhesion to mammalian cells and increased host cell death, indicating a functional virulence mechanism.

Methodological Strengths

  • Whole-genome sequencing with pan-genome analysis linked to clinical outcomes and adjusted multivariable modeling
  • Experimental validation of complement resistance, adhesion, and cytotoxicity supporting causative mechanisms

Limitations

  • Observational association limits causal inference for human mortality despite mechanistic support
  • Single-pathogen focus and modest sample size (N=193) may limit generalizability across regions and lineages

Future Directions: Validate ETT2/ETT2-AR prognostic value in multicenter cohorts; develop rapid diagnostics; test anti-T3SS strategies and complement-modulating adjuncts in preclinical infection models.

BACKGROUND: Escherichia coli has an extensive accessory genome, though its role in affecting patient mortality is unknown. METHODS: We performed whole genome sequencing with E. coli bacteremia isolates. Pan-genome analysis was used to identify flexible genomic islands associated with in-hospital attributable mortality. Genomic islands of interest were investigated experimentally. RESULTS: We included 193 E. coli genomes. Two genomic islands were co-present within 41 (21%) genomes and associated with increased attributable mortality in an adjusted analysis (Odds ratio 3.0; 95% confidence interval 1.1-7.9; p=0.03). The two genomic islands together contain genes homologous to a type III secretion system (T3SS): 1) E. coli type III secretion system 2 (ETT2), encoding genes homologous to a T3SS basal body and needle complex, and 2) an ETT2 accessory region (ETT2-AR) encoding genes homologous to a T3SS needle tip, translocases, and adhesin. ETT2/ETT2-AR increased resistance to complement-mediated growth restriction by inhibiting classical complement pathway activation and impacted E. coli-host cell interactions by increasing adhesion to and death of mammalian cells. CONCLUSIONS: Genomic islands ETT2 and ETT2-AR are homologous to a T3SS, co-localize within specific E. coli lineages, associate with increased mortality, and increase bacterial virulence through resistance to complement and enhanced host cell adhesion and death.

2. Mechanism of adipose-derived stem cell-derived extracellular vesicles affecting macrophage efferocytosis by mediating ADAM17/MerTK in the apoptosis of tubular epithelial cells after sepsis-associated acute kidney injury.

71.5Level VCase-control
Translational research : the journal of laboratory and clinical medicine · 2025PMID: 40403963

ADSC-derived extracellular vesicles enhanced macrophage efferocytosis and M2 polarization by downregulating ADAM17 and soluble MerTK while increasing membrane MerTK, thereby reducing tubular epithelial apoptosis and inflammation after S-AKI in mice. Loss- and gain-of-function experiments (MerTK silencing and ADAM17 upregulation) partially abrogated these protective effects.

Impact: Identifies a druggable EV-mediated ADAM17/MerTK axis that restores macrophage clearance of apoptotic cells and mitigates renal injury after sepsis. Supports cell-free regenerative strategies for S-AKI.

Clinical Implications: ADSC-EVs or ADAM17/MerTK-targeted approaches could be developed as adjunctive therapies to limit tubular apoptosis and inflammation in S-AKI. Biomarkers such as sMerTK may help monitor response.

Key Findings

  • ADSC-EVs decreased ADAM17 and soluble MerTK while increasing membrane MerTK, boosting macrophage efferocytosis and M2 polarization in S-AKI mouse kidneys and LPS-stimulated renal macrophages.
  • ADSC-EVs reduced serum urea/creatinine, KIM-1, pro-inflammatory cytokines, and tubular epithelial apoptosis, indicating renal protection after sepsis.
  • MerTK silencing partially reversed EV effects, and ADAM17 upregulation in vivo attenuated EV-mediated protection, implicating the ADAM17/MerTK axis.

Methodological Strengths

  • In vivo CLP S-AKI model with comprehensive functional, histologic, and molecular readouts
  • Mechanistic rigor with gain/loss-of-function (si-MerTK, oe-ADAM17) and EV interventions

Limitations

  • Preclinical murine and cell culture data; human validation is lacking
  • EV characterization and dosing regimens for clinical translation require standardization

Future Directions: Define EV dose-response and biodistribution, validate ADAM17/MerTK biomarkers in human S-AKI, and test EV-based or small-molecule ADAM17/MerTK modulators in large-animal models.

OBJECTIVE: This study explored the molecular mechanism of adipose-derived stem cell-derived extracellular vesicles (ADSC-EVs) improving post-sepsis-associated acute kidney injury (S-AKI) tubular epithelial cell (TEC) apoptosis by modulating ADAM17/MerTK-mediated macrophage efferocytosis. METHODS: The S-AKI mouse model was established by caecal ligation and puncture and intravenously injected with ADSC-EVs. Mouse kidney macrophages were cultured with LPS, cultured with EVs while transfecting with oe-ADAM17 or si-MerTK, then incubated with Jurkat cells. Mouse serum urea and creatinine, and KIM-1, efferocytosis- and apoptosis-related protein, inflammatory factor, cytokine, and soluble MerTK (sMerTK) levels were determined using colorimetric assay, immunohistochemistry, Western blot, and ELISA. Renal tubular injury, TEC apoptosis, macrophage efferocytosis, and M1/M2 polarization levels were assessed via HE staining, TUNEL staining, immunofluorescence, and flow cytometry, respectively. In vivo validation experiments were conducted. RESULTS: S-AKI mice displayed elevated levels of serum urea, creatinine, KIM-1, pro-inflammatory factors, pro-apoptotic proteins and ADAM17 protein, decreased anti-apoptotic protein and MerTK protein levels, and diminished M2 polarization. ADSC-EVs down-regulated ADAM17 and sMerTK, and increased cell membrane MerTK, macrophage recognition of apoptotic cells and efferocytosis, and M2 polarization in renal tissues of S-AKI mice and LPS-induced mouse renal macrophages, indicating that ADSC-EVs regulated ADAM17/MerTK-mediated macrophage efferocytosis and promoted M2 polarization. MerTK silencing partially reversed ADSC-EVs-regulated LPS-induced mouse renal macrophage efferocytosis and M2 polarization. In vivo, ADAM17 upregulation partly averted ADSC-EVs-regulated post-S-AKI TEC apoptosis in mouse renal tissues. CONCLUSION: ADSC-EVs down-regulated sMerTK level and up-regulated macrophage membrane MerTK protein level by modulating ADAM17 to promote macrophage efferocytosis and ameliorate post-S-AKI TEC apoptosis and inflammation.

3. Neutrophil-derived exosomes promote sepsis-related multiple organ dysfunction through the induction of neutrophil extracellular trap formation.

70Level VCase-control
International immunopharmacology · 2025PMID: 40403502

Exosomes from LPS-stimulated neutrophils increased NET formation and induced multi-organ injury in mice; in vitro, they promoted ROS-dependent NETs. Proteomics identified exosomal MMP9 as a key mediator that triggers NETs via p38 MAPK, and clinical analyses linked plasma exosomal MMP9 to sepsis severity and prognosis.

Impact: Reveals a mechanistic EV-mediated pathway (exosomal MMP9→p38 MAPK→NETs) that drives sepsis-related multi-organ dysfunction and suggests a prognostic biomarker and therapeutic target.

Clinical Implications: Plasma exosomal MMP9 could assist in risk stratification, while inhibitors of MMP9 or NET formation may mitigate organ injury. EV-pathway targeting offers a novel adjunct to anti-inflammatory strategies.

Key Findings

  • LPS-stimulated neutrophil-derived exosomes enhanced NET formation in vivo and caused multi-organ inflammation and tissue injury.
  • In vitro, these exosomes promoted ROS-dependent NET formation in healthy donor neutrophils.
  • Proteomics identified enriched exosomal MMP9, which induced NETs via p38 MAPK; plasma exosomal MMP9 levels correlated with sepsis severity/prognosis.

Methodological Strengths

  • Combined in vivo mouse model, in vitro human neutrophil assays, and proteomic profiling
  • Mechanistic pathway dissection implicating MMP9 and p38 MAPK with clinical correlation

Limitations

  • Sample sizes and dosing paradigms are not detailed; therapeutic blockade not directly tested in vivo
  • Exogenous exosome administration may not fully mirror endogenous dynamics in human sepsis

Future Directions: Test MMP9 or p38 MAPK inhibition on NETs and organ injury in sepsis models; standardize EV isolation/quantification; validate exosomal MMP9 prognostic value in multicenter clinical cohorts.

Our previous studies have demonstrated that neutrophils play a key role in septic organ injury partly through the excessive formation of neutrophil extracellular traps (NETs) and that exosomes participate in the regulation of NET formation during sepsis. Therefore, this study aimed to determine whether neutrophil-derived exosomes promote the formation of NETs and induce multiple organ dysfunction during sepsis. Initially, polymorphonuclear neutrophil (PMN)-derived exosomes following in vitro stimulation with PBS or LPS (1 μg/mL) for 6 h. In vivo, PMN-derived exosomes were intravenously administered to wild-type C57BL/6 mice. Then, histopathological injury and NET formation in multiple organs were evaluated. In vitro, PMN-derived exosomes were cocultured with PMNs freshly isolated from healthy volunteers, and subsequently, NET formation and activation of associated molecular pathways were detected. Administration of LPS-stimulated PMN-derived exosomes in mice significantly enhanced NET formation, resulting in multi-organ inflammation and tissue injury. In vitro coculture experiments also demonstrated that exosomes from LPS-stimulated PMNs promote ROS-dependent NET formation. Proteomic analysis revealed enrichment of matrix metalloproteinase 9 (MMP9) expression in exosomes from LPS-stimulated PMNs, and further mechanistic investigations showed that exosomal MMP9 induced NET formation through the p38 MAPK pathway. Clinical data analysis suggests a close association between sepsis severity/prognosis and plasma-derived exosomal MMP9 expression levels. PMN-derived exosomes facilitate the excessive formation of NETs in sepsis, leading to the subsequent development of multiple organ dysfunction. This discovery reveals a novel role for PMN-derived exosomes in the pathogenesis of sepsis-related multiple organ dysfunction and suggests their potential as prognostic indicators for this condition.